PYXIS Oncology Rings The Nasdaq Stock Market Closing Bell
Pyxis Oncology (Nasdaq: PYXS), a preclinical oncology company developing a diversified portfolio of novel, next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Lara S. Sullivan, Chief Executive Officer, rings the Closing Bell.